510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K031565Substantially Equivalent

Xpect Influenza A/b

Remel Inc, Lenexa KS / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K031565 is the FDA 510(k) clearance record for XPECT INFLUENZA A/B, a class II device, cleared for Remel, Inc. on under FDA product code PSZ (Devices Detecting Influenza A, B, And C Virus Antigens). FDA's definition for product code PSZ reads: "An influenza virus antigen detection test system is a device intended for the qualitative detection of influenza viral antigens directly from clinical specimens in patients with signs and symptoms of respiratory infection". FDA records list 107 510(k) clearances for Remel, Inc., from to . As of , FDA records show no recalls naming K031565.

Clearance record

Decision date
Received
(59 days to decision)
Product code
PSZ Devices Detecting Influenza A, B, And C Virus Antigens
Regulation
21 CFR 866.3328
Device class
Class II
Review panel
Microbiology
Applicant
Remel, Inc. 12076 Santa Fe Dr., Lenexa KS
510(k) summary
Summary PDF
Third party review
No

Clearances, product code PSZ

Trailing 12 months
2 clearances under product code PSZ in the twelve months to October 2026, January 2026 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code PSZ, trailing twelve months
MonthClearances
November 20250
December 20250
January 20261
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20261
October 20260